SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-049000
Filing Date
2024-02-28
Accepted
2024-02-28 06:15:52
Documents
14
Period of Report
2024-02-22
Items
Item 1.03: Bankruptcy or Receivership

Document Format Files

Seq Description Document Type Size
1 8-K d800225d8k.htm   iXBRL 8-K 22190
  Complete submission text file 0001193125-24-049000.txt   142712

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bxrx-20240222.xsd EX-101.SCH 2502
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bxrx-20240222_lab.xml EX-101.LAB 17946
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bxrx-20240222_pre.xml EX-101.PRE 11229
16 EXTRACTED XBRL INSTANCE DOCUMENT d800225d8k_htm.xml XML 3732
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39101 | Film No.: 24690038
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)